PS

Prajakta Santosh Nimbalkar

Active Director Director DIN 10776179
DIN 10776179 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value •••• Premium profile

About Prajakta Santosh Nimbalkar

Data last updated:

Prajakta Santosh Nimbalkar is a Director at Forepetals Life Sciences Private Limited (since 2024). The company operates in Pharma. Forepetals Life Sciences Private Limited reported revenue of ₹48,736 (FY 2025).

DIN 10776179
Primary Designation Director
Industry Pharma
First Appointment 20 Sep 2024
Oldest Company Age 3 yrs
Largest company Forepetals Life Sciences Private Limited · ₹48,736 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Sep 20242022₹48,736 (FY 2025)Active

Directorship timeline

Open interactive timeline →
Forepetals Life Sciences Private Limited
Premium access

Shareholding and investment profile for Prajakta Santosh Nimbalkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prajakta Santosh Nimbalkar

Prajakta Santosh Nimbalkar currently holds 1 directorship: Forepetals Life Sciences Private Limited (Director, since 20 Sep 2024, revenue ₹48,736 (FY 2025)).

Prajakta Santosh Nimbalkar was first appointed on 20 Sep 2024 as Director at Forepetals Life Sciences Private Limited.

The current boards of Prajakta Santosh Nimbalkar's companies include Chandrakant Appasaheb Chavan (Forepetals Life Sciences Private Limited), Harshad Subhash Amrutkar (Forepetals Life Sciences Private Limited), Swaroop Manikrao Deshmukh (Forepetals Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available